一、Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry. 2001;49(6):487-499. 二、Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull. 2004;30(2):255-264.. 三、Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J Clin Psychiatry. 2009;70(7):990-996 四、Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv. 2004;55(8):886-891. 五、Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res. 2014;152(2-3):408-414 六、Effectiveness of long-acting injectable antipsychotics: a clinical perspective. Evid Based Ment Health. 2015;18(2):36-39. 七、What is the role of long-acting injectable antipsychotics in the treatment of schizophrenia? J Clin Psychiatry 2014; 75(11):1261-1262. 八、The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. Ther Adv Psychopharmacol 2014;4(5):198-219. 九、Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29823 patients with schizophrenia. JAMA Psychiatry. 2017;74(7):686-693. 十、A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.. Am J Psychiatry. 2011;168(6):603-609. 十一、台灣精神醫學會與康復之友聯盟製作【思覺失調症三部曲】影片YouTube播放清單連結:https://bit.ly/2H89Idf |